Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Muhammad Mahdi Nashatizadeh
Observed names:
M. M. Nashatizadeh,
M.M. Nashatizadeh,
Muhammad Nashatizadeh
Institution:
University of Kansas Medical Center
Observed institutions:
University of Kansas,
Baylor College of Medicine,
University of Florida,
University of Kansas Medical Center
ORCID:
0000-0003-1351-2059
Observed ORCID:
0000-0003-1351-2059
OpenAlex ID:
A5108800038
Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?
2020
·
Sharon Lynch
, Sara Baker
, et al.
·
Multiple Sclerosis and Related Disorders
·
33
Case Report: Expanding the Genetic and Phenotypic Spectrum of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
2020
·
Parham Habibzadeh
, Zahra Tabatabaei
, et al.
·
Frontiers in Genetics
·
15
PDF
Education Research: Patient telephone calls in a movement disorders center
2009
·
O. R. Adam
, J. M. Ferrara
, et al.
·
Neurology
·
11
PDF
Exploring the High-Grade and Refractory Neurotoxicity of Teclistamab: An Underreported Entity
2023
·
Forat Lutfi
, Al-Ola Abdallah
, et al.
·
Cureus
·
6
PDF
The gut microbiota–brain–CAR T cell axis: a systematic review of gut microbiome modulation and its impact on neurological complications and treatment responses in CAR T cell therapy
2026
·
Ashvath Arumugam Pillai
, Sai K. Reddy Pasya
, et al.
·
Frontiers in Immunology
·
4
PDF
Delayed fatal neurotoxicity in post CAR-T cell therapy for multiple myeloma, a case report
2026
·
Hamza Khoudari
, Abdalla Shoaib
, et al.
·
Leukemia Research Reports
·
4
Neurocognitive testing to predict ICANS post-CAR T.
2024
·
William Wesson
, Lauren Scott
, et al.
·
Journal of Clinical Oncology
·
3
PDF
The Use of the Montreal Cognitive Assessment to Predict Neurotoxicity Post CD19 and BCMA CART
2024
·
Hannah Katz
, Lauren N Scott
, et al.
·
Blood
·
2
Utilization of Investigations for Neurotoxicity in CD19 and BCMA CART Recipients
2024
·
Lauren N Scott
, William Wesson
, et al.
·
Blood
·
1
Utility of neurotoxicity investigations in CD19 and BCMA CART recipients with ICANS
2025
·
Lauren N. Scott
, Benjamin Hane
, et al.
·
Blood Immunology & Cellular Therapy
A description of processing speed, learning and memory in people with multiple sclerosis aged 55+
2025
·
Sharon Lynch
, Sara Baker
, et al.
·
Multiple Sclerosis and Related Disorders
PDF
Neurocognitive Testing to Predict ICANS Post-Chimeric Antigen (CAR) T-Cell Therapy
2024
·
William Wesson
, Lauren Scott
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
14
Citation count:
79
H-index:
4
I10-index:
3
Year
Topic
Type